Literature DB >> 17374363

Plasma annexin A5 level relates inversely to the severity of coronary stenosis.

Lambertus J H van Tits1, Waander L van Heerde, Gerly M van der Vleuten, Jacqueline de Graaf, Diederick E Grobbee, Lucy P L van de Vijver, Anton F Stalenhoef, Hans M Princen.   

Abstract

Exogenous radiolabeled annexin A5 is taken up by atherosclerotic tissue. We measured endogenous plasma annexin A5 and circulating oxidized low-density lipoprotein (oxLDL), a biochemical marker of atherosclerosis, in men with either severe angiographically determined coronary stenosis (n=90) or no or only minor stenosis (n=96). Men without history of cardiac disease or treatment and free of plaques in the carotid artery (by ultrasonography) were taken as controls (n=87). Opposite to oxLDL, annexin A5 decreased at increasing severity of stenosis. OxLDL was lowest and annexin A5 was highest in controls. Percentage differences between groups were higher for annexin A5 than for oxLDL, and highest for oxLDL/annexin A5 ratio. The oxLDL/annexin A5 ratio is a better marker of the severity of coronary stenosis than oxLDL alone, may reflect the presence and extent of the atherosclerotic cardiovascular disease, and might prove useful for preclinical screening purposes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374363     DOI: 10.1016/j.bbrc.2007.03.020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  The IgG and IgM isotypes of anti-annexin A5 antibodies: relevance for primary antiphospholipid syndrome.

Authors:  Mirjana Bećarević
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

2.  Relationship between the Soluble F11 Receptor and Annexin A5 in African Americans Patients with Type-2 Diabetes Mellitus.

Authors:  Ajibola Adedayo; Ayobami Eluwole; Fasika Tedla; Arye Kremer; Muhammad Khan; Nicole Mastrogiovanni; Carl Rosenberg; Paul Dreizen; John La Rosa; Louis Salciccioli; Mohamed Boutjdir; Mary Ann Banerji; Clinton Brown; Jason Lazar; Moro Salifu; Ahmed Bakillah
Journal:  Biomedicines       Date:  2022-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.